These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 19457162)
81. Differential changes in GPR55 during microglial cell activation. Pietr M; Kozela E; Levy R; Rimmerman N; Lin YH; Stella N; Vogel Z; Juknat A FEBS Lett; 2009 Jun; 583(12):2071-6. PubMed ID: 19464294 [TBL] [Abstract][Full Text] [Related]
82. Extracellular α-synuclein--a possible initiator of inflammation in Parkinson's disease. Ren WQ; Tian ZM; Yin F; Sun JZ; Zhang JN Pharmazie; 2016 Feb; 71(2):51-5. PubMed ID: 27004367 [TBL] [Abstract][Full Text] [Related]
83. Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. Polazzi E; Altamira LE; Eleuteri S; Barbaro R; Casadio C; Contestabile A; Monti B J Neurochem; 2009 Jul; 110(2):545-56. PubMed ID: 19457129 [TBL] [Abstract][Full Text] [Related]
84. Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression. Yongjun Y; Shuyun H; Lei C; Xiangrong C; Zhilin Y; Yiquan K J Neuroimmunol; 2013 Jul; 260(1-2):1-8. PubMed ID: 23707077 [TBL] [Abstract][Full Text] [Related]
85. Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia. Ellert-Miklaszewska A; Dabrowski M; Lipko M; Sliwa M; Maleszewska M; Kaminska B Glia; 2013 Jul; 61(7):1178-90. PubMed ID: 23650109 [TBL] [Abstract][Full Text] [Related]
86. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease. Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570 [TBL] [Abstract][Full Text] [Related]
88. Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors. Krenz A; Falkenburger BH; Gerhardt E; Drinkut A; Schulz JB J Neurochem; 2009 Jan; 108(1):139-46. PubMed ID: 19094062 [TBL] [Abstract][Full Text] [Related]
89. Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Kovacs GG; Milenkovic IJ; Preusser M; Budka H Mov Disord; 2008 Aug; 23(11):1608-12. PubMed ID: 18649394 [TBL] [Abstract][Full Text] [Related]
90. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin. Milner R Glia; 2009 May; 57(7):714-23. PubMed ID: 18985734 [TBL] [Abstract][Full Text] [Related]
91. Functional protein kinase arrays reveal inhibition of p-21-activated kinase 4 by alpha-synuclein oligomers. Danzer KM; Schnack C; Sutcliffe A; Hengerer B; Gillardon F J Neurochem; 2007 Dec; 103(6):2401-7. PubMed ID: 17883396 [TBL] [Abstract][Full Text] [Related]
92. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant. Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765 [TBL] [Abstract][Full Text] [Related]
93. Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells. Qian JJ; Cheng YB; Yang YP; Mao CJ; Qin ZH; Li K; Liu CF Neurosci Lett; 2008 Apr; 435(2):142-6. PubMed ID: 18342443 [TBL] [Abstract][Full Text] [Related]
94. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Harrison IF; Smith AD; Dexter DT Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397 [TBL] [Abstract][Full Text] [Related]
95. Expression of alpha-synuclein is increased in the hippocampus of rats with high levels of innate anxiety. Chiavegatto S; Izidio GS; Mendes-Lana A; Aneas I; Freitas TA; Torrão AS; Conceição IM; Britto LR; Ramos A Mol Psychiatry; 2009 Sep; 14(9):894-905. PubMed ID: 18427558 [TBL] [Abstract][Full Text] [Related]
96. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models. Guo Y; Wei X; Yan H; Qin Y; Yan S; Liu J; Zhao Y; Jiang F; Lou H FASEB J; 2019 Nov; 33(11):12164-12174. PubMed ID: 31370707 [TBL] [Abstract][Full Text] [Related]
97. The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition. Wu KC; Liou HH; Kao YH; Lee CY; Lin CJ Neurobiol Dis; 2017 Aug; 104():61-72. PubMed ID: 28476637 [TBL] [Abstract][Full Text] [Related]
98. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease. Schneider JS; Singh G; Williams CK; Singh V Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351 [TBL] [Abstract][Full Text] [Related]